Month: September 2022

– The first and only treatment in Europe to treat patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening genetic disorder that often progresses rapidly in infants with a median overall survival age of about four years. – European Commission (EC) decision is based on the efficacy and safety data collected to date compared to data from a natural history study. – NULIBRY was BridgeBio’s first FDA-approved therapeutic; Sentynl acquired global rights to NULIBRY in March 2022. PALO ALTO, Calif. and SOLANA BEACH, Calif. and AHMEDABAD, India, Sept. 20, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company that focuses on genetic diseases and cancers, and Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. MONTREAL, Sept. 20, 2022 (GLOBE NEWSWIRE) — Dominion Water Reserves Corp. (“DWR” or the “Corporation”) (CSE:DWR), is pleased to announce that it has completed the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement of up to $3,350,000 (the “Private Placement”) in units of the Corporation (each, an “Unit”) at a price of $100 per Unit. Private Placement Together with the previously announced closing of the First Tranche on July 5, 2022, a total of 33,350 Units were sold and issued under the Private Placement, for aggregate gross proceeds of $3,335,000. Under the Second Tranche, the Corporation sold 30,000 Units to 9474-8431 Quebec Inc. (“9474”) and certain joint actors for aggregate gross...

CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced the promotion of Phillip Samayoa, Ph.D., to chief strategy officer. Dr. Samayoa has led strategy, corporate and portfolio development at Generation Bio since he joined the company in 2017, most recently serving as senior vice president. “Phillip has been instrumental in building a holistic strategy for platform development that will enable its application to multiple genetic medicine modalities,” said Geoff McDonough, M.D., president and chief executive officer of Generation Bio. “In this new role Phillip will lead corporate strategy, business development and discovery research, enabling the integration of these key strategic activities.” “We...

CENTREVILLE, Va., Sept. 20, 2022 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) was selected by U.S. Army Combat Capabilities Development Command, Chemical Biological Center (DEVCOM CBC) for an award on its Scientific, Technical Engineering, and Program Support Services (STEPSS) indefinite delivery, indefinite quantity (IDIQ) contract. The 10-year IDIQ, a multiple award contract with a program ceiling value of $869 million, will support the U.S. Army by providing acquisition life-cycle chemical and biological defense research, development, test, and evaluation support. “We stand ready to support DEVCOM CBC as they deliver on their vision of providing innovative chemical and biological defense capabilities to advance national security and global combat operations,” said Jon Moretta, president of Parsons’ engineered systems business...

Vancouver, BC, Sept. 20, 2022 (GLOBE NEWSWIRE) — Bessor Minerals Inc. (NEX:BST.H) (“Bessor” or the “Corporation”) is pleased to announce that, further to its news releases dated September 6, 2022, it has completed its previously announced non-brokered private ‎placement offering on September 19, 2022, pursuant to which Bessor issued 5,000,000 common ‎shares in the capital of Bessor (“Common Shares”) at a price of $0.05 per Common Share, for ‎aggregate gross proceeds of $250,000 (the “Private Placement”). All securities issued in ‎connection with the Private Placement are subject to a hold period of four months and one day ‎from September 19, 2022. The net proceeds from the Private Placement will be used for: potential exploration of Bessor’s properties; potential future acquisitions; and general working capital. The...

IBI awarded new and extended contracts involving IBI’s Advanced Traffic Management Systems solutions TORONTO, Sept. 20, 2022 (GLOBE NEWSWIRE) —  Global design and technology firm, IBI Group Inc. (TSX: IBG) (“IBI” or the “Company”), has recently been awarded a new statewide contract and contract extension with the Florida Department of Transportation for its Advanced Traffic Management Systems (ATMS) portfolio. The contracts are expected to improve the State’s ability to manage transportation networks and improve traveller safety and ease of travel. The continuation of work with the Florida Department of Transportation will allow IBI to build upon its working relationship and offer improved, intelligent solutions based on a history of working knowledge. IBI’s new contract with the Florida Department of Transportation (FDOT) includes...

Pursuant to section 38 of the Danish Capital Markets Act, FirstFams A/S hereby announces to have received information from Henrik Hougaard, that he through his ownership of Thoraso Aps, Thoraso Holding ApS and private now owns between 15 and 19.99 percent of the shares in FirstFarms A/S. Best regards,FirstFarms A/S For further information:Please visit our website www.firstfarms.com or contact CEO Anders H. Nørgaard on phone +45 75 86 87 87. About FirstFarms:FirstFarms is a Danish stock exchange listed company. We operate FirstFarms with responsibility for the surrounding communities, and we deliver highest quality which is primarily sold locally. We act on new opportunities, that create value for our investors and for the surroundings. Every day, we work on creating a more sustainable company.Attachment(20) Major shareholder...

The Extraordinary General Meeting of Norsk Hydro ASA was held on September 20, 2022. All proposals on the agenda were adopted, including the proposal to distribute an additional dividend of NOK 1.45 per share. The dividend will be paid on September 30, 2022, to shareholders as of September 20, 2022, and who are listed in the Norwegian Central Securities Depository as of September 22, 2022. The share will be traded ex-dividend from September 21, 2022. The minutes of the Extraordinary General Meeting are attached and also available on www.hydro.com/generalmeeting. Investor contact: Line Haugetraa +47 41406376 Line.Haugetraa@hydro.comThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentNorsk Hydro ASA – Minutes from Extraordinary General...

VANCOUVER, British Columbia, Sept. 20, 2022 (GLOBE NEWSWIRE) — Arctic Fox Minerals Corp. (CSE: FOXY) (the “Company” or “Arctic Fox”) is pleased to announce the appointment of Robert Gietl as the new Chief Executive Officer (“CEO”) of the Company effective September 15, 2022. Mr. Gietl brings extensive executive management and business development experience to the Company. He is an experienced business leader with a proven track record of implementing organizational change including through entry into new markets, fiscal accountability, and business plan execution. He has increased business performance in a wide variety of sectors across Canada and has worked diligently to align stakeholders’ goals and values. Dixon Lawson has stepped down from his duties as CEO. Management and Directors of Arctic Fox would like to take this opportunity...